RxDoctor Payments Data

Timothy Dobin, DO

Gastroenterology · Lakewood, CONPI 1649624347

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.5% of the total across 459 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by AbbVie at 27.5% of the total. 2025 is the largest year on record at $3,347, 5.0 times the $665 reported in 2019.

$11,583in general payments, 2019–2025

Across 459 payments — averaging $25.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • Johnson & Johnson$1K
  • Phathom Pharmaceuticals, Inc.$657
  • Regeneron Healthcare Solutions, Inc.$652
  • Gilead$599
  • plus $4K from 27 others

What the payments were for

  • Grants$3353%
  • Food & beverage$10,95195%
  • Education$2973%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,583 in reported general payments places this provider in the 85th percentile of 304 gastroenterology providers in Colorado.

See all gastroenterology providers in Colorado

Medicare billing

Part B allowed, 2024
$78,250
Medicare patients
278
Services billed
609

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pantoprazole Sodium170$1,707
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl94$1,538
Ursodiol13$771
Omeprazole30$241
Dicyclomine Hcl18$218
Ondansetron OdtOndansetron17$204
Famotidine14$178

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Lakewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →